Clinical Trial Update: Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update shows Modified Zipper Therapy for AQP4-IgG positive Neuromyeltis Optica Spectrum Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Modified Zipper Therapy

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Neuromyelitis Optica Spectrum Disorders (NMOSD) | Phase 4 | Status: RECRUITING